Combined targeted therapy and immunotherapy in melanoma: a review of the impact on the tumor microenvironment and outcomes of early clinical trials

Therapeutic Advances in Medical Oncology
Meredith S Pelster, Rodabe N Amaria

Abstract

The development of BRAF and MEK inhibitors (BRAFis and MEKis) and immune checkpoint inhibitors have changed the management of advanced stage melanoma and improved the outcomes of patients with this malignancy. However, both therapeutic approaches have limitations, including a limited duration of benefit in subsets of BRAF-mutant melanoma patients treated with targeted therapy and a lower overall response rate without a clear predictive biomarker in patients treated with checkpoint inhibitors. Preclinical and translational data have shown that BRAFis and MEKis alter the tumor microenvironment to make it more amenable to immunotherapy and have provided the scientific rationale for combing BRAFis and MEKis with immunotherapy. In this review, the initial studies demonstrating the impact of BRAFis and MEKis on the expression of melanoma differentiation antigens, T-cell infiltration, and the balance of immune stimulatory and immune suppressive cells and cytokines are addressed. Preclinical work on the combination of targeted therapy with BRAFis and MEKis with immunotherapy are reviewed, highlighting improved tumor responses in mouse models of BRAF-mutated melanoma treated with combinatorial strategies. Lastly, data from early clinica...Continue Reading

References

Jun 28, 2006·The Journal of Experimental Medicine·Hidetoshi SumimotoYutaka Kawakami
Dec 14, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·James S WilmottRichard A Scolyer
Oct 26, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Xiaofeng JiangF Stephen Hodi
Dec 4, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chengwen LiuPatrick Hwu
Jan 12, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dennie T FrederickJennifer A Wargo
Mar 14, 2013·Oncoimmunology·Bishu SapkotaBrian P Pollack
Apr 5, 2013·The New England Journal of Medicine·Antoni RibasJedd Wolchok
Nov 20, 2013·Oncoimmunology·Zachary A CooperJennifer A Wargo
Feb 4, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·James S WilmottGeorgina V Long
Jun 7, 2014·Cancer Immunology Research·Zachary A CooperJennifer A Wargo
Sep 4, 2014·Cancer Immunology Research·Shannon M SteinbergMary Jo Turk
Sep 30, 2014·The New England Journal of Medicine·James LarkinAntoni Ribas
Jan 23, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hojabr KakavandRichard A Scolyer
Feb 11, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antoni Ribas, Keith T Flaherty
Mar 20, 2015·Science Translational Medicine·Siwen Hu-LieskovanAntoni Ribas
May 4, 2016·Oncoimmunology·Jessica C HasselAlexander H Enk
Jan 18, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Drew C DenigerSteven A Rosenberg
Jan 27, 2017·Oncoimmunology·Marcel A DekenChristian U Blank
Sep 12, 2017·The New England Journal of Medicine·Jedd D WolchokJames Larkin
Oct 1, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P A AsciertoA Ribas

❮ Previous
Next ❯

Citations

Sep 5, 2019·Cells·João M A DelouHelena L Borges
Jan 3, 2020·American Journal of Clinical Pathology·Sara E MonacoUdai S Kammula
Jan 7, 2020·Expert Review of Anticancer Therapy·Dimitrios C ZiogasHelen Gogas
Dec 4, 2019·Expert Opinion on Pharmacotherapy·Michael J CarrJonathan S Zager
Apr 22, 2020·Neurosurgery·Cecilia JiangMohammad K Khan
May 30, 2020·Cell Research·Yonina R Murciano-GoroffJedd D Wolchok
May 22, 2020·Expert Review of Anticancer Therapy·Qian QinMatthew D Galsky
Jul 2, 2020·International Journal of Molecular Sciences·Anna M CzarneckaPiotr Rutkowski
Jul 11, 2020·Cancers·Ilaria ProiettiConcetta Potenza
Jul 15, 2020·Human Vaccines & Immunotherapeutics·Ernesto RossiGiampaolo Tortora
Aug 6, 2020·Cell Cycle·Kristina Riegel, Krishnaraj Rajalingam
Feb 18, 2020·Cytopathology : Official Journal of the British Society for Clinical Cytology·Sara E MonacoLiron Pantanowitz
Aug 9, 2020·Cancer Control : Journal of the Moffitt Cancer Center·Christopher J WhelanRobert A Gatenby
Aug 29, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Michael DouganBernardo L Rapoport
Sep 17, 2020·Oncoimmunology·Julie Le NaourGuido Kroemer
Nov 17, 2019·International Journal of Molecular Sciences·Filippo PaganiFilippo Pietrantonio
Jul 26, 2019·Cancers·Vasileios AtsavesFrancois X Claret
Oct 11, 2020·Journal for Immunotherapy of Cancer·Olivier MichielinPaolo Antonio Ascierto
Jan 20, 2021·Trends in Biochemical Sciences·Nimi Vashi, Samuel F Bakhoum
Dec 9, 2020·Molecular & Cellular Proteomics : MCP·Annika NeldeJuliane Sarah Walz
Nov 12, 2020·International Journal of Molecular Sciences·Aleksandra SimiczyjewDorota Nowak
Dec 29, 2020·Journal for Immunotherapy of Cancer·Pier Francesco FerrucciUNKNOWN KEYNOTE-022 international team
Jan 10, 2021·International Journal of Molecular Sciences·Paola SavoiaOttavio Cremona
Feb 24, 2021·Immunopharmacology and Immunotoxicology·Zhaoxue HuHuibin Zhang
Feb 16, 2021·Molecular & Cellular Proteomics : MCP·Annika NeldeJuliane S Walz
Mar 26, 2021·American Journal of Clinical Dermatology·Dimitrios C ZiogasHelen Gogas
Jun 1, 2021·Signal Transduction and Targeted Therapy·Lei ZhongShengyong Yang
Jun 30, 2021·Cancer Treatment Reviews·Federica GiuglianoPaolo A Ascierto
Apr 28, 2021·Cancer Research·Emma SaultersLekh N Dahal
Aug 28, 2021·Biomolecules·Cian D'Arcy, Christina Kiel

❮ Previous
Next ❯

Methods Mentioned

BETA
MDA
biopsies
biopsy

Clinical Trials Mentioned

NCT01656642
NCT01988896
NCT02130466
NCT02027961
NCT01673854
NCT02910700
NCT02967692
NCT01400451
NCT01767454
NCT02908672

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Sarah J WelshGeorgina V Long
© 2022 Meta ULC. All rights reserved